Molecular cell biology of Charcot-Marie-Tooth disease

Neurogenetics

Volumn 4, Issue 1, 2002, Pages 1-15

  Berger, Philipp ^a   Young, Peter ^b   Suter, Ueli ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Axonopathy; Charcot Marie Tooth disease; Myelinopathy; Peripheral nervous system; Schwann cells

Indexed keywords

CELL INTERACTION; CLINICAL FEATURE; CYTOLOGY; DISEASE CLASSIFICATION; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MOLECULAR BIOLOGY; NERVE CELL; NEUROPATHY; PRIORITY JOURNAL; REVIEW; SCHWANN CELL;

CHARCOT-MARIE-TOOTH DISEASE; HUMANS; MYELIN PROTEINS;

ANIMALIA;

EID: 0036524611     PISSN: 13646745     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10048-002-0130-z     Document Type: Review

References (201)

1. Lobsiger CS, Taylor V, Suter U (2002) The early life of a Schwann cell. Biol Chem (in press)
2. Arroyo EJ, Scherer SS (2000) On the molecular architecture of myelinated fibers. Histochem Cell Biol 113:1-18
3. Peles E, Salzer JL (2000) Molecular domains of myelinated axons. Curr Opin Neurobiol 10:558-565
4. Martini R (2001) The effect of myelinating Schwann cells on axons. Muscle Nerve 24:456-466
5. Jessen KR, Mirsky R (1999) Schwann cells and their precursors emerge as major regulators of nerve development. Trends Neurosci 22:402-410
6. Skre H (1974) Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin Genet 6:98-118
7. Dyck PJ, Chance P, Lebo R, Carney JA (1993) Hereditary motor and sensory neuropathies. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF (eds) Peripheral neuropathy, 3rd edn. Saunders, Philadelphia, pp1094-1136
8. Nelis E, Haites N, Van Broeckhoven C (1999) Mutations in the peripheral myelin genes and associated genes in inherited peripheral neuropathies. Hum Mutat 13:11-28
9. Warner LE, Garcia CA, Lupski JR (1999) Hereditary peripheral neuropathies: clinical forms, genetics, and molecular mechanisms. Annu Rev Med 50:263-275
10. Young P, Suter U (2001) Disease mechanisms and potential therapeutic strategies in Charcot-Marie-Tooth disease. Brain Res Brain Res Rev 36:213-221
11. Vance JM (1999) Charcot-Marie-Tooth disease type 2. Ann N Y Acad Sci 883:42-46
12. Suter U, Welcher AA, Ozcelik T, Snipes GJ, Kosaras B, Francke U, Billings GS, Sidman RL, Shooter EM (1992) Trembler mouse carries a point mutation in a myelin gene. Nature 356:241-244
13. Suter U, Moskow JJ, Welcher AA, Snipes GJ, Kosaras B, Sidman RL, Buchberg AM, Shooter EM (1992) A leucine-to-proline mutation in the putative first transmembrane domain of the 22-kDa peripheral myelin protein in the trembler-J mouse. Proc Natl Acad Sci USA 89:4382-4386
14. Taylor V, Zgraggen C, Naef R, Suter U (2000) Membrane topology of peripheral myelin protein 22. J Neurosci Res 62:15-27
15. Welcher AA, Suter U, De Leon M, Snipes GJ, Shooter EM (1991) A myelin protein is encoded by the homologue of a growth arrest-specific gene. Proc Natl Acad Sci USA 88:7195-7199
16. Spreyer P, Kuhn G, Hanemann CO, Gillen C, Schaal H, Kuhn R, Lemke G, Muller HW (1991) Axon-regulated expression of a Schwann cell transcript that is homologous to a 'growth arrest-specific' gene. EMBO J 10:3661-3668
17. Snipes GJ, Suter U, Welcher AA, Shooter EM (1992) Characterization of a novel peripheral nervous system myelin protein (PMP-22/SR13). J Cell Biol 117:225-238
18. Haney C, Snipes GJ, Shooter EM, Suter U, Garcia C, Griffin JW, Trapp BD (1996) Ultrastructural distribution of PMP22 in Charcot-Marie-Tooth disease type 1A. J Neuropathol Exp Neurol 55:290-299
19. Jetten AM, Suter U (2000) The peripheral myelin protein 22 and epithelial membrane protein family. Prog Nucleic Acid Res Mol Biol 64:97-129
20. Hayasaka K, Himoro M, Sato W, Takada G, Uyemura K, Shimizu N, Bird TD, Conneally PM, Chance PF (1993) Charcot-Marie-Tooth neuropathy type 1B is associated with mutations of the myelin P0 gene. Nat Genet 5:31-34
21. Warner LE, Hilz MJ, Appel SH, Killian JM, Kolodry EH, Karpati G, Carpenter S, Watters GV, Wheeler C, Witt D, Bodell A, Nelis E, Van Broeckhoven C, Lupski JR (1996) Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination. Neuron 17:451-460
22. Bergoffen J, Scherer SS, Wang S, Scott MO, Bone LJ, Paul DL, Chen K, Lensch MW, Chance PF, Fischbeck KH (1993) Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 262:2039-2042
23. Warner LE, Mancias P, Butler IJ, McDonald CM, Keppen L, Koob KG, Lupski JR (1998) Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat Genet 18:382-384
24. Suter U (1997) Myelin: keeping nerves well wrapped up. Curr Biol 7:R21-R23
25. Balice-Gordon RJ, Bone LJ, Scherer SS (1998) Functional gap junctions in the schwann cell myelin sheath. J Cell Biol 142:1095-1104
26. Topilko P, Schneider-Maunoury S, Levi G, Baron-Van Evercooren A, Chennoufi AB, Seitanidou T, Babinet C, Chamay P (1994) Krox-20 controls myelination in the peripheral nervous system. Nature 371:796-799
27. Nagarajan R, Svaren J, Le N, Araki T, Watson M, Milbrandt J (2001) EGR2 mutations in inherited neuropathies dominantnegatively inhibit myelin gene expression. Neuron 30:355-368
28. Kalaydjieva L, Gresham D, Gooding R, Heather L, Baas F, Jonge R de, Blechschmidt K, Angelicheva D, Chandler D, Worsley P, Rosenthal A, King RH, Thomas PK (2000) N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom. Am J Hum Genet 67:47-58
29. Bolino A, Muglia M, Conforti FL, LeGuern E, Salih MA, Georgiou DM, Christodoulou K, Hausmanowa-Petrusewicz I, Mandich P, Schenone A, Gambardella A, Bono F, Quattrone A, Devoto M, Monaco AP (2000) Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat Genet 25:17-19
30. Guilbot A, Williams A, Ravise N, Verny C, Brice A, Sherman DL, Brophy PJ, LeGuern E, Delague V, Bareil C, Megarbane A, Claustres M (2001) A mutation in periaxin is responsible for CMT4F, an autosomal recessive form of Charcot-Marie-Tooth disease. Hum Mol Genet 10:415-421
31. Boerkoel CF, Takashima H, Stankiewicz P, Garcia CA, Leber SM, Rhee-Morris L, Lupski JR (2001) Periaxin mutations cause recessive Dejerine-Sottas neuropathy. Am J Hum Genet 68:325-333
32. Mersiyanova IV, Perepelov AV, Polyakov AV, Sitnikov VF, Dadali EL, Oparin RB, Petrin AN, Evgrafov OV (2000) A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am J Hum Genet 67:37-46
33. Bomont P, Cavalier L, Blondeau F, Ben Hamida C, Belal S, Tazir M, Demir E, Topaloglu H, Korinthenberg R, Tuysuz B, Landrieu P, Hentati F, Koenig M (2000) The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy. Nat Genet 26:370-374
34. Zhao C, Takita J, Tanaka Y, Setou M, Nakagawa T, Takeda S, Yang HW, Terada S, Nakata T, Takei Y, Saito M, Tsuji S, Hayashi Y, Hirokawa N (2001) Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 105:587-597
35. Lupski JR, Oca Luna RM de, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, Saucedo-Cardenas O, Barker DF, Killian JM, Garcia CA, Chakravarti A, Patel PI (1991) DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 66:219-232
36. Chance PF, Alderson MK, Leppig KA, Lensch MW, Matsunami N, Smith B, Swanson PD, Odelberg SJ, Disteche CM, Bird TD (1993) DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 72:143-151
37. Boerkoel CF, Inoue K, Reiter LT, Warner LE, Lupski JR (1999) Molecular mechanisms for CMT1A duplication and HNPP deletion. Ann N Y Acad Sci 883:22-35
38. Patel PI, Roa BB, Welcher AA, Schoener-Scott R, Trask BJ, Pentao L, Snipes GJ, Garcia CA, Francke U, Shooter EM, et al (1992) The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nat Genet 1:159-165
39. Matsunami N, Smith B, Ballard L, Lensch MW, Robertson M, Albertsen H, Hanemann CO, Muller HW, Bird TD, White R, et al (1992) Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth 1A. Nat Genet 1:176-179
40. Timmerman V, Nelis E, Van Hul W, Nieuwenhuijsen BW, Chen KL, Wang S, Ben Othman K, Cullen B, Leach RJ, Hanemann CO, et al (1992) The peripheral myelin protein gene PMP22 is contained within the Charcot-Marie-Tooth disease type 1A duplication. Nat Genet 1:171-175
41. Valentijn LJ, Bolhuis PA, Zorn I, Hoogendijk JE, Bosch N van den, Hensels GW, Stanton VP Jr, Housman DE, Fischbeck KH, Ross DA, et al (1992) The peripheral myelin gene PMP-22/GAS-3 is duplicated in Charcot-Marie-Tooth disease type 1A. Nat Genet 1:166-170
42. Vallat JM, Sindou P, Preux PM, Tabaraud F, Milor AM, Couratier P, LeGuern E, Brice A (1996) Ultrastructural PMP22 expression in inherited demyelinating neuropathies. Ann Neurol 39:813-817
43. Magyar JP, Martini R, Ruelicke T, Aguzzi A, Adlkofer K, Dembic Z, Zielasek J, Toyka KV, Suter U (1996) Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J Neurosci 16:5351-5360
44. Huxley C, Passage E, Manson A, Putzu G, Figarella-Branger D, Pellissier JF, Fontes M (1996) Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum Mol Genet 5:563-569
45. Norreel JC, Jamon M, Riviere G, Passage E, Fontes M, Clarac F (2001) Behavioural profiling of a murine Charcot-Marie-Tooth disease type 1A model. Eur J Neurosci 13:1625-1634
46. Sancho S, Magyar JP, Aguzzi A, Suter U (1999) Distal axonopathy in peripheral nerves of PMP22-mutant mice. Brain 122:1563-1577
47. Sancho S, Young P, Suter U (2001) Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A. Brain 124:2177-2187
48. Sereda M, Griffiths I, Puhlhofer A, Stewart H, Rossner MJ, Zimmermann F, Magyar JP, Schneider A, Hund E, Meinck H-M, Suter U, Nave KA (1996) A rat transgenic model for Charcot-Marie-Tooth disease. Neuron 16:1049-1060
49. Niemann S, Sereda MW, Suter U, Griffiths IR, Nave KA (2000) Uncoupling of myelin assembly and schwann cell differentiation by transgenic overexpression of peripheral myelin protein 22. J Neurosci 20:4120-4128
50. Nobbio L, Mancardi G, Grandis M, Levi G, Suter U, Nave KA, Windebank AJ, Abbruzzese M, Schenone A (2001) PMP22 transgenic dorsal root ganglia cultures show myelin abnormalities similar to those of human CMT1A. Ann Neurol 50:47-55
51. LeGuern E, Gouider R, Mabin D, Tardieu S, Birouk N, Parent P, Bouche P, Brice A (1997) Patients homozygous for the 17p11.2 duplication in Charcot-Marie-Tooth type 1A disease. Ann Neurol 41:104-108
52. Ohnishi A, Yamamoto T, Ikeda M (2000) Small axons relative to number of myelin lamellae in Charcot-Marie-Tooth disease 1A with peripheral myelin protein 22 gene duplication. J Uoeh 22:107-117
53. Krajewski KM, Lewis RA, Fuerst DR, Turansky C, Hinderer SR, Garbern J, Kamholz J, Shy ME (2000) Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. Brain 123:1516-1527
54. Kamholz J, Menichella D, Jani A, Garbern J, Lewis RA, Krajewski KM, Lilien J, Scherer SS, Shy ME (2000) Charcot-Marie-Tooth disease type 1: molecular pathogenesis to gene therapy. Brain 123:222-233
55. Hai M, Bidichandani SI, Hogan ME, Patel PI (2001) Competitive binding of triplex-forming oligonucleotides in the two alternate promoters of the PMP22 gene. Antisense Nucleic Acid Drug Dev 11:233-246
56. Mansuy IM, Suter U (2000) Mouse genetics in cell biology. Exp Physiol 85:661-679
57. Perea J, Robertson A, Tolmachova T, Muddle J, King RH, Ponsford S, Thomas PK, Huxley C (2001) Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A. Hum Mol Genet 10:1007-1018
58. Nicholson GA, Valentijn LJ, Cherryson AK, Kennerson ML, Bragg TL, DeKroon RM, Ross DA, Pollard JD, McLeod JG, Bolhuis PA, et al (1994) A frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies. Nat Genet 6:263-266
59. Young P, Wiebusch H, Stogbauer F, Ringelstein B, Assmann G, Funke H (1997) A novel frameshift mutation in PMP22 accounts for hereditary neuropathy with liability to pressure palsies. Neurology 48:450-452
60. Windebank AJ (1993) Inherited recurrent focal neuropathies. In: Dyck PJ, Thomas PK, Grffin JW, Low PA, Poduslo JF (eds) Peripheral neuropathy, 3rd edn. Saunders, Philadelphia, pp 1137-1148
61. Verhagen WI, Gabreels-Festen AA, Wensen PJ van, Joosten EM, Vingerhoets HM, Gabreels FJ, Graaf R de (1993) Hereditary neuropathy with liability to pressure palsies: a clinical, electroneurophysiological and morphological study. J Neurol Sci 116:176-184
62. Amato AA, Gronseth GS, Callerame KJ, Kagan-Hallet KS, Bryan WW, Barohn RJ (1996) Tomaculous neuropathy: a clinical and electrophysiological study in patients with and with-out 1.5-Mb deletions in chromosome 17p11.2. Muscle Nerve 19:16-22
63. Sander S, Ouvrier RA, McLeod JG, Nicholson GA, Pollard JD (2000) Clinical syndromes associated with tomacula or myelin swellings in sural nerve biopsies. J Neurol Neurosurg Psychiatry 68:483-488
64. Stogbauer F, Young P, Kuhlenbaumer G, De Jonghe P, Timmerman V (2000) Hereditary recurrent focal neuropathies: clinical and molecular features. Neurology 54.546-551
65. Adlkofer K, Martini R, Aguzzi A, Zielasek J, Toyka KV, Suter U (1995) Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nat Genet 11:274-280
66. Adlkofer K, Frei R, Neuberg DH, Zielasek J, Toyka KV, Suter U (1997) Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy. J Neurosci 17:4662-4671
67. Maycox PR, Ortuno D, Burrola P, Kuhn R, Bieri PL, Arrezo JC, Lemke G (1997) A transgenic mouse model for human hereditary neuropathy with liability to pressure palsies. Mol Cell Neurosci 8:405-416
68. De Jonghe P, Timmerman V, Nelis E, Martin JJ, Van Broeckhoven C (1997) Charcot-Marie-Tooth disease and related peripheral neuropathies. J Peripher Nerv Syst 2:370-387
69. Gabreels-Festen AA, Bolhuis PA, Hoogendijk JE, Valentijn LJ, Eshuis EJ, Gabreels FJ (1995) Charcot-Marie-Tooth disease type 1A: morphological phenotype of the 17p duplication versus PMP22 point mutations. Acta Neuropathol (Berl) 90:645-649
70. Ionasescu VV, Searby C, Greenberg SA (1996) Dejerine-Sottas disease with sensorineural hearing loss, nystagmus, and peripheral facial nerve weakness: de novo dominant point mutation of the PMP22 gene. J Med Genet 33:1048-1049
71. Roa BB, Garcia CA, Suter U, Kulpa DA, Wise CA, Mueller J, Welcher AA, Snipes GJ, Shooter EM, Patel PI, et al (1993) Charcot-Marie-Tooth disease type 1A. Association with a spontaneous point mutation in the PMP22 gene. N Engl J Med 329:96-101
72. Ionasescu VV, Ionasescu R, Searby C, Neahring R (1995) Dejerine-Sottas disease with de novo dominant point mutation of the PMP22 gene. Neurology 45:1766-1767
73. Valentijn LJ, Baas F, Wolterman RA, Hoogendijk JE, Bosch NH van den, Zorn I, Gabreels-Festen AW, Visser M de, Bolhuis PA (1992) Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A. Nat Genet 2:288-291
74. Ionasescu VV, Searby CC, Ionasescu R, Chatkupt S, Patel N, Koenigsberger R (1997) Dejerine-Sottas neuropathy in mother and son with same point mutation of PMP22 gene. Muscle Nerve 20:97-99
75. Suter U, Welcher AA, Snipes GJ (1993) Progress in the molecular understanding of hereditary peripheral neuropathies reveals new insights into the biology of the peripheral nervous system. Trends Neurosci 16:50-56
76. Suter U, Snipes GJ (1995) Biology and genetics of hereditary motor and sensory neuropathies. Annu Rev Neurosci 18:45-75
77. Notterpek L, Shooter EM, Snipes GJ (1997) Upregulation of the endosomal-lysosomal pathway in the trembler-J neuropathy. J Neurosci 17:4190-4200
78. Robertson AM, King RH, Muddle JR, Thomas PK (1997) Abnormal Schwann cell/axon interactions in the Trembler-J mouse. J Anat 190:423-432
79. Robertson AM, Huxley C, King RH, Thomas PK (1999) Development of early postnatal peripheral nerve abnormalities in Trembler-J and PMP22 transgenic mice. J Anat 195:331-339
80. Isaacs AM, Davies KE, Hunter AJ, Nolan PM, Vizor L, Peters J, Gale DG, Kelsell DP, Latham ID, Chase JM, Fisher EM, Bouzyk MM, Potter A, Masih M, Walsh FS, Sims MA, Doncaster KE, Parsons CA, Martin J, Brown SD, Rastan S, Spurr NK, Gray IC (2000) Identification of two new Pmp22 mouse mutants using large-scale mutagenesis and a novel rapid mapping strategy. Hum Mol Genet 9:1865-1871
81. Suh JG, Ichihara N, Saigoh K, Nakabayashi O, Yamanishi T, Tanaka K, Wada K, Kikuchi T (1997) An in-frame deletion in peripheral myelin protein-22 gene causes hypomyelination and cell death of the Schwann cells in the new Trembler mutant mice. Neuroscience 79:735-744
82. Adlkofer K, Naef R, Suter U (1997) Analysis of compound heterozygous mice reveals that the Trembler mutation can behave as a gain-of-function allele. J Neurosci Res 49:671-680
83. Naef R, Adlkofer K, Lescher B, Suter U (1997) Aberrant protein trafficking in Trembler suggests a disease mechanism for hereditary human peripheral neuropathies. Mol Cell Neurosci 9:13-25
84. D'Urso D, Prior R, Greiner-Petter R, Gabreels-Festen AA, Muller HW (1998) Overloaded endoplasmic reticulum-Golgi compartments, a possible pathomechanism of peripheral neuropathies caused by mutations of the peripheral myelin protein PMP22. J Neurosci 18:731-740
85. Tobler AR, Notterpek L, Naef R, Taylor V, Suter U, Shooter EM (1999) Transport of Trembler-J mutant peripheral myelin protein 22 is blocked in the intermediate compartment and affects the transport of the wild-type protein by direct interaction. J Neurosci 19:2027-2036
86. Hanemann CO, D'Urso D, Gabreels-Festen AA, Muller HW (2000) Mutation-dependent alteration in cellular distribution of peripheral myelin protein 22 in nerve biopsies from Charcot-Marie-Tooth type 1A. Brain 123:1001-1006
87. Colby J, Nicholson R, Dickson KM, Orfali W, Naef R, Suter U, Snipes GJ (2000) PMP22 carrying the trembler or trembler-J mutation is intracellularly retained in myelinating Schwann cells. Neurobiol Dis 7:561-573
88. Naef R, Suter U (1999) Impaired intracellular trafficking is a common disease mechanism of PMP22 point mutations in peripheral neuropathies. Neurobiol Dis 6:1-14
89. Pareek S, Suter U, Snipes GJ, Welcher AA, Shooter EM, Murphy RA (1993) Detection and processing of peripheral myelin protein PMP22 in cultured Schwann cells. J Biol Chem 268:10372-10379
90. Ryan MC, Notterpek L, Tobler AR, Liu N, Shooter EM (2000) Role of the peripheral myelin protein 22 N-linked glycan in oligomer stability. J Neurochem 75:1465-1474
91. Sanders CR, Ismail-Beigi F, McEnery MW (2001) Mutations of peripheral myelin protein 22 result in defective trafficking through mechanisms which may be common to diseases involving tetraspan membrane proteins. Biochemistry 40:9453-9459
92. Pareek S, Notterpek L, Snipes GJ, Naef R, Sossin W, Laliberté J, Iacampo S, Suter U, Shooter EM, Murphy RA (1997) Neurons promote the translocation of peripheral myelin protein 22 into myelin. J Neurosci 17:7754-7762
93. Notterpek L, Ryan MC, Tobler AR, Shooter EM (1999) PMP22 accumulation in aggresomes: implications for CMT1A pathology. Neurobiol Dis 6:450-460
94. Suter U, Snipes GJ, Schoener-Scott R, Welcher AA, Pareek S, Lupski JR, Murphy RA, Shooter EM, Patel PI (1994) Regulation of tissue-specific expression of alternative peripheral myelin protein-22 (PMP22) gene transcripts by two promoters. J Biol Chem 269:25795-25808
95. Bosse F, Zoidl G, Wilms S, Gillen CP, Kuhn HG, Muller HW (1994) Differential expression of two mRNA species indicates a dual function of peripheral myelin protein PMP22 in cell growth and myelination. J Neurosci Res 37:529-537
96. Huehne K, Rautenstrauss B (2001) Transcriptional startpoints and methylation patterns in the PMP22 promoters of peripheral nerve, leukocytes and tumor cell lines. Int J Mol Med 7:669-675
97. Saberan-Djoneidi D, Sanguedolce V, Assouline Z, Levy N, Passage E, Fontes M (2000) Molecular dissection of the Schwann cell specific promoter of the PMP22 gene. Gene 248:223-231
98. Hai M, Bidichandani SI, Patel PI (2001) Identification of a positive regulatory element in the myelin-specific promoter of the PMP22 gene. J Neurosci Res 65:508-519
99. Desarnaud F, Do Thi AN, Brown AM, Lemke G, Suter U, Baulieu EE, Schumacher M (1998) Progesterone stimulates the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells. J Neurochem 71:1765-1768
100. Desarnaud F, Bidichandani S, Patel PI, Baulieu EE, Schumacher M (2000) Glucocorticosteroids stimulate the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells. Brain Res 865:12-16
101. Melcangi RC, Magnaghi V, Cavarretta I, Zucchi I, Bovolin P, D'Urso D, Martini L (1999) Progesterone derivatives are able to influence peripheral myelin protein 22 and P0 gene expression: possible mechanisms of action. J Neurosci Res 56:349-357
102. Manfioletti G, Ruaro ME, Del Sal G, Philipson L, Schneider C (1990) A growth arrest-specific (gas) gene codes for a membrane protein. Mol Cell Biol 10:2924-2930
103. Bosse F, Brodbeck J, Muller HW (1999) Post-transcriptional regulation of the peripheral myelin protein gene PMP22/gas3. J Neurosci Res 55:164-177
104. Brancolini C, Marzinotto S, Schneider C (1997) Susceptibility to p53 dependent apoptosis correlates with increased levels of Gas2 and Gas3 proteins. Cell Death Differ 4:247-253
105. Zoidl G, Blass-Kampmann S, D'Urso D, Schmalenbach C, Muller HW (1995) Retroviral- mediated gene transfer of the peripheral myelin protein PMP22 in Schwann cells: modulation of cell growth. EMBO J 14:1122-1128
106. Zoidl G, D'Urso D, Blass-Kampmann S, Schmalenbach C, Kuhn R, Muller HW (1997) Influence of elevated expression of rat wild-type PMP22 and its mutant PMP22Trembler on cell growth of NIH3T3 fibroblasts. Cell Tissue Res 287:459-470
107. Fabbretti E, Edomi P, Brancolini C, Schneider C (1995) Apoptotic phenotype induced by overexpression of wild-type gas3/PMP22: its relation to the demyelinating peripheral neuropathy CMT1A. Genes Dev 9:1846-1856
108. Brancolini C, Marzinotto S, Edomi P, Agostoni E, Fiorentini C, Muller HW, Schneider C (1999) Rho-dependent regulation of cell spreading by the tetraspan membrane protein Gas3/PMP22. Mol Biol Cell 10:2441-2459
109. Weiner JA, Fukushima N, Contos JJ, Scherer SS, Chun J (2001) Regulation of Schwann cell morphology and adhesion by receptor-mediated lysophosphatidic acid signaling. J Neurosci 21:7069-7078
110. Brancolini C, Edomi P, Marzinotto S, Schneider C (2000) Exposure at the cell surface is required for gas3/PMP22 to regulate both cell death and cell spreading: implication for the Charcot-Marie-Tooth type 1A and Dejerine-Sottas diseases. Mol Biol Cell 11:2901-2914
111. Attardi LD, Reczek EE, Cosmas C, Demicco EG, McCurrach ME, Lowe SW, Jacks T (2000) PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes Dev 14:704-718
112. Hildebrandt T, Dijk MC van, Muijen GN van, Weidle UH (2001) Loss of heterozygosity of gene THW is frequently found in melanoma metastases. Anticancer Res 21:1071-1080
113. Christophe-Hobertus C, Szpirer C, Guyon R, Christophe D (2001) Identification of the gene encoding Brain Cell Membrane Protein 1 (BCMP1), a putative four-transmembrane protein distantly related to the Peripheral Myelin Protein 22/Epithelial Membrane Proteins and the Claudins. BMC Genomics 2:3
114. Notterpek L, Roux KJ, Amici SA, Yazdanpour A, Rahner C, Fletcher BS (2001) Peripheral myelin protein 22 is a constituent of intercellular junctions in epithelia. Proc Natl Acad Sci USA 20:20
115. Wulf P, Bernhardt RR, Suter U (1999) Characterization of peripheral myelin protein 22 in zebrafish (zPMP22) suggests an early role in the development of the peripheral nervous system. J Neurosci Res 57:467-478
116. Agostoni E, Gobessi S, Brancolini C, Schneider C (1999) Identification and characterization of a new member of the gas3/PMP22 gene family in C. elegans. Gene 234:267-274
117. Taylor V, Welcher AA, Program AE, Suter U (1995) Epithelial membrane protein-1, peripheral myelin protein 22, and lens membrane protein 20 define a novel gene family. J Biol Chem 270:28824-28833
118. Baechner D, Liehr T, Hameister H, Altenberger H, Grehl H, Suter U, Rautenstrauss B (1995) Widespread expression of the peripheral myelin protein-22 gene (PMP22) in neural and non-neural tissues during murine development. J Neurosci Res 42:733-741
119. Parmantier E, Cabon F, Braun C, D'Urso D, Muller HW, Zalc B (1995) Peripheral myelin protein-22 is expressed in rat and mouse brain and spinal cord motoneurons. Eur J Neurosci 7:1080-1088
120. Parmantier E, Braun C, Thomas JL, Peyron F, Martinez S, Zalc B (1997) PMP-22 expression in the central nervous system of the embryonic mouse defines potential transverse segments and longitudinal columns. J Comp Neurol 378:159-172
121. Hagedorn L, Suter U, Sommer L (1999) P0 and PMP22 mark a multipotent neural crest-derived cell type that displays community effects in response to TGF-beta family factors. Development 126:3781-3794
122. Hanemann CO, Gabreels-Festen AA, Stoll G, Muller HW (1997) Schwann cell differentiation in Charcot-Marie-Tooth disease type 1A (CMT1A): normal number of myelinating Schwann cells in young CMT1A patients and neural cell adhesion molecule expression in onion bulbs. Acta Neuropathol (Berl) 94:310-315
123. Hanemann CO, Rosenbaum C, Kupfer S, Wosch S, Stoegbauer F, Muller HW (1998) Improved culture methods to expand Schwann cells with altered growth behaviour from CMT1A patients. Glia 23:89-98
124. Atanasoski S, Scherer SS, Nave KA, Suter U (2001) Proliferation of Schwann cells and regulation of cyclin D1 expression in an animal model of Charcot-Marie-Tooth disease type 1. J Neurosci Res 67:443-449
125. Atanasoski S, Shumas S, Dickson C, Scherer SS, Suter U (2001) Differential cycline D1 requirements of proliferating Schwann cells during development and after injury. Mol Cell Neurosci 18:581-592
126. Erdem S, Mendell JR, Sahenk Z (1998) Fate of Schwann cells in CMT1A and HNPP: evidence for apoptosis. J Neuropathol Exp Neurol 57:635-642
127. Hanemann CO, Gabreels-Fasten AA, Muller HW, Stoll G (1996) Low affinity NGF receptor expression in CMT1A nerve biopsies of different disease stages. Brain 119:1461-1469
128. Neuberg DH, Sancho S, Suter U (1999) Altered molecular architecture of peripheral nerves in mice lacking the peripheral myelin protein 22 or connexin32. J Neurosci Res 58:612-623
129. Lemke G, Axel R (1985) Isolation and sequence of a cDNA encoding the major structural protein of peripheral myelin. Cell 40:501-508
130. Lemke G, Lamar E, Patterson J (1988) Isolation and analysis of the gene encoding peripheral myelin protein zero. Neuron 1:73-83
131. Filbin MT, Walsh FS, Trapp BD, Pizzey JA, Tennekoon GI (1990) Role of myelin P0 protein as a homophilic adhesion molecule. Nature 344:871-872
132. Hayasaka K, Himoro M, Sawaishi Y, Nanao K, Takahashi T, Takada G, Nicholson GA, Ouvrier RA, Tachi N (1993) De novo mutation of the myelin P0 gene in Dejerine-Sottas disease (hereditary motor and sensory neuropathy type III). Nat Genet 5:266-268
133. De Jonghe P, Timmerman V, Ceuterick C, Nelis E, De Vriendt E, Lofgren A, Vercruyssen A, Verellen C, Van Maldergem L, Martin JJ, Van Broeckhoven C (1999) The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype. Brain 122:281-290
134. Young P, Grote K, Kuhlenbaumer G, Debus O, Kurlemann H, Halfter H, Funke H, Ringelstein EB, Stogbauer F (2001) Mutation analysis in Chariot-Marie Tooth disease type 1: point mutations in the MPZ gene and the GJBI gene cause comparable phenotypic heterogeneity. J Neurol 248:410-415
135. Plante-Bordeneuve V, Guiochon-Mantel A, Lacroix C, Lapresle J, Said G (1999) The Roussy-Levy family: from the original description to the gene. Ann Neurol 46:770-773
136. Shapiro L, Doyle JP, Hensley P, Colman DR, Hendrickson WA (1996) Crystal structure of the extracellular domain from P0, the major structural protein of peripheral nerve myelin. Neuron 17:435-449
137. Gabreels-Festen AA, Hoogendijk JE, Meijerink PH, Gabreels FJ, Bolhuis PA, Beersum S van, Kulkens T, Nelis E, Jennekens FG, Visser M de, Engelen BG van, Van Broeckhoven C, Mariman EC (1996) Two divergent types of nerve pathology in patients with different P0 mutations in Charcot-Marie-Tooth disease. Neurology 47:761-765
138. Wong MH, Filbin MT (1994) The cytoplasmic domain of the myelin P0 protein influences the adhesive interactions of its extracellular domain. J Cell Biol 126:1089-1097
139. Wong MH, Filbin MT (1996) Dominant-negative effect on adhesion by myelin Po protein truncated in its cytoplasmic domain. J Cell Biol 134:1531-1541
140. Xu W, Shy M, Kamholz J, Elferink L, Xu G, Lilien J, Balsamo J (2001) Mutations in the cytoplasmic domain of P0 reveal a role for PKC-mediated phosphorylation in adhesion and myelination. J Cell Biol 155:439-446
141. Giese KP, Martini R, Lemke G, Soriano P, Schachner M (1992) Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 71:565-576
142. Xu W, Manichella D, Jiang H, Vallat JM, Lilien J, Baron P, Scarlato G, Kamholz J, Shy ME (2000) Absence of P0 leads to the dysregulation of myelin gene expression and myelin morphogenesis. J Neurosci Res 60:714-724
143. Frei R, Motzing S, Kinkelin I, Schachner M, Koltzenburg M, Martini R (1999) Loss of distal axons and sensory Merkel cells and features indicative of muscle denervation in hindlimbs of P0-deficient mice. J Neurosci 19:6058-6067
144. Martini R, Zielasek J, Toyka KV, Giese KP, Schachner M (1995) Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nat Genet 11:281-286
145. Zhang K, Filbin MT (1998) Myelin Po protein mutated at Cys2l has a dominant-negative effect on adhesion of wild type Po. J Neurosci Res 53:1-6
146. Shy ME, Arroyo E, Sladky J, Menichella D, Jiang H, Xu W, Kamholz J, Scherer SS (1997) Heterozygous P0 knockout mice develop a peripheral neuropathy that resembles chronic inflammatory demyelinating polyneuropathy (CIDP). J Neuropathol Exp Neurol 56:811-821
147. Schmid CD, Stienekemeier M, Oehen S, Bootz F, Zielasek J, Gold R, Toyka KV, Schachner M, Martini R (2000) Immune deficiency in mouse models for inherited peripheral neuropathies leads to improved myelin maintenance. J Neurosci 20:729-735
148. Maurer M, Schmid CD, Bootz F, Zielasek J, Toyka KV, Oehen S, Martini R (2001) Bone marrow transfer from wild-type mice reverts the beneficial effect of genetically mediated immune deficiency in myelin mutants. Mol Cell Neurosci 17:1094-1101
149. Carenini S, Maurer M, Werner A, Blazyca H, Toyka KV, Schmid CD, Raivich G, Martini R (2001) The role of macrophages in demyelinating peripheral nervous system of mice heterozygously deficient in p0. J Cell Biol 152:301-308
150. Wrabetz L, Feltri ML, Quattrini A, Imperiale D, Previtali S, D'Antonio M, Martini R, Yin X, Trapp BD, Zhou L, Chiu SY, Messing A (2000) P(0) glycoprotein overexpression causes congenital hypomyelination of peripheral nerves. J Cell Biol 148:1021-1034
151. Chen H, Kusyk CJ, Tuck-Muller CM, Martinez JE, Dorand RD, Wertelecki W (1994) Confirmation of proximal lq duplication using fluorescence in situ hybridization. Am J Med Genet 50:28-31
152. Previtali SC, Quattrini A, Fasolini M, Panzeri MC, Villa A, Filbin MT, Li W, Chiu SY, Messing A, Wrabetz L, Feltri ML (2000) Epitope-tagged P(0) glycoprotein causes Charcot-Marie-Tooth-like neuropathy in transgenic mice. J Cell Biol 151:1035-1046
153. D'Urso D, Ehrhardt P, Muller HW (1999) Peripheral myelin protein 22 and protein zero: a novel association in peripheral nervous system myelin. J Neurosci 19:3396-3403
154. Carenini S, Neuberg D, Schachner M, Suter U, Martini R (1999) Localization and functional roles of PMP22 in peripheral nerves of P0-deficient mice. Glia 28:256-264
155. Scherer SS, Bone LJ, Deschenes SM, Abel A, Balice-Gordon RJ, Fischbeck KH (1999) The role of the gap junction protein connexin32 in the pathogenesis of X-linked Charcot-Marie-Tooth disease. Novartis Found Symp 219:175-185
156. Anzini P, Neuberg DH, Schachner M, Nelles E, Willecke K, Zielasek J,
157. Scherer SS, Xu YT, Nelles E, Fischbeck K, Willecke K, Bone LJ (1998) Connexin32-null mice develop demyelinating peripheral neuropathy. Glia 24:8-20
158. Abel A, Bone LJ, Messing A, Scherer SS, Fischbeck KH (1999) Studies in transgenic mice indicate a loss of connexin32 function in X-linked Charcot-Marie-Tooth disease. J Neuropathol Exp Neurol 58:702-710
159. Abrams CK, Oh S, Ri Y, Bargiello TA (2000) Mutations in connexin 32: the molecular and biophysical bases for the X-linked form of Charcot-Marie-Tooth disease. Brain Res Brain Res Rev 32:203-214
160. Deschenes SM, Walcott JL, Wexler TL, Scherer SS, Fischbeck KH (1997) Altered trafficking of mutant connexin32. J Neurosci 17:9077-9084
161. Silander K, Meretoja P, Pihko H, Juvonen V, Issakainen J, Aula P, Savontaus ML (1997) Screening for connexin 32 mutations in Charcot-Marie-Tooth disease families with possible X-linked inheritance. Hum Genet 100:391-397
162. Mirsky R, Jessen KR (1999) The neurobiology of Schwann cells. Brain Pathol 9:293-311
163. Murphy P, Topilko P, Schneider-Maunoury S, Seitanidou T, Baron-Van Evercooren A, Charnay P (1996) The regulation of Krox-20 expression reveals important steps in the control of peripheral glial cell development. Development 122:2847-2857
164. Voiculescu O, Charnay P, Schneider-Maunoury S (2000) Expression pattern of a Krox-20/Cre knock-in allele in the developing hindbrain, bones, and peripheral nervous system. Genesis 26:123-126
165. Zorick TS, Syroid DE, Brown A, Gridley T, Lemke G (1999) Krox-20 controls SCIP expression, cell cycle exit and susceptibility to apoptosis in developing myelinating Schwann cells. Development 126:1397-1406
166. Musso M, Balestra P, Bellone E, Cassandrini D, Di Maria E, Doria LL, Grandis M, Mancardi GL, Schenone A, Levi G, Ajmar F, Mandich P (2001) The D355V mutation decreases EGR2 binding to an element within the Cx32 promoter. Neurobiol Dis 8:700-706
167. Boerkoel CF, Takashima H, Bacino CA, Daentl D, Lupski JR (2001) EGR2 mutation R359W causes a spectrum of Dejerine-Sottas neuropathy. Neurogenetics 3:153-157
168. Gillespie CS, Sherman DL, Blair GE, Brophy PJ (1994) Periaxin, a novel protein of myelinating Schwann cells with a possible role in axonal ensheathment. Neuron 12:497-508
169. Scherer SS, Xu YT, Bannerman PG, Sherman DL, Brophy PJ (1995) Periaxin expression in myelinating Schwann cells: modulation by axon-glial interactions and polarized localization during development. Development 121:4265-4273
170. Dytrych L, Sherman DL, Gillespie CS, Brophy PJ (1998) Two PDZ domain proteins encoded by the murine periaxin gene are the result of alternative intron retention and are differentially targeted in Schwann cells. J Biol Chem 273:5794-5800
171. Sherman DL, Brophy PJ (2000) A tripartite nuclear localization signal in the PDZ-domain protein L-periaxin. J Biol Chem 275:4537-4540
172. Sherman DL, Fabrizi C, Gillespie CS, Brophy PJ (2001) Specific disruption of a schwann cell dystrophin-related protein complex in a demyelinating neuropathy. Neuron 30:677-687
173. Gillespie CS, Sherman DL, Fleetwood-Walker SM, Cottrell DF, Tait S, Garry EM, Wallace VC, Ure J, Griffiths IR, Smith A, Brophy PJ (2000) Peripheral demyelination and neuropathic pain behavior in periaxin-deficient mice. Neuron 26:523-531
174. Gillespie CS, Lee M, Fantes JF, Brophy PJ (1997) The gene encoding the Schwann cell protein periaxin localizes on mouse chromosome 7 (Prx). Genomics 41:297-298
175. Delague V, Bareil C, Tuffery S, Bouvagnet P, Chouery E, Koussa S, Maisonobe T, Loiselet J, Megarbane A, Claustres M (2000) Mapping of a new locus for autosomal recessive demyelinating Charcot-Marie-Tooth disease to 19q 13.1-13.3 in a large consanguineous Lebanese family: exclusion of MAG as a candidate gene. Am J Hum Genet 67:236-243
176. Bolino A, Levy ER, Muglia M, Conforti FL, LeGuern E, Salih MA, Georgiou DM, Christodoulou RK, Hausmanowa-Petrusewicz I, Mandich P, Gambardella A, Quattrone A, Devoto M, Monaco AP (2000) Genetic refinement and physical mapping of the CMT4B gene on chromosome 11q22. Genomics 63:271-278
177. Gambardella A, Bolino A, Muglia M, Valentino P, Bono F, Oliveri RL, Sabatelli M, Brancolini V, Van Broeckhoven C, Romeo G, Devoto M, Quattrone A (1998) Genetic heterogeneity in autosomal recessive hereditary motor and sensory neuropathy with focally folded myelin sheaths (CMT4B). Neurology 50:799-801
178. Laporte J, Blondeau F, Buj-Bello A, Tentler D, Kretz C, Dahl N, Mandel JL (1998) Characterization of the myotubularin dual specificity phosphatase gene family from yeast to human. Hum Mol Genet 7:1703-1712
179. Taylor GS, Maehama T, Dixon JE (2000) Inaugural article: myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate. Proc Natl Acad Sci USA 97:8910-8915
180. Blondeau F, Laporte J, Bodin S, Superti-Furga G, Payrastre B, Mandel JL (2000) Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway. Hum Mol Genet 9:2223-2229
181. Doerks T, Strauss M, Brendel M, Bork P (2000) GRAM, a novel domain in glucosyltransferases, myotubularins and other putative membrane-associated proteins. Trends Biochem Sci 25:483-485
182. Cui X, De Vivo I, Slany R, Miyamoto A, Firestein R, Cleary ML (1998) Association of SET domain and myotubularin@-related proteins modulates growth control. Nat Genet 18:331-337
183. Wishart MJ, Taylor GS, Slama JT, Dixon JE (2001) PTEN and myotubularin phosphoinositide phosphatases: bringing bioinformatics to the lab bench. Curr Opin Cell Biol 13:172-181
184. Houlden H, King RH, Wood NW, Thomas PK, Reilly MM (2001) Mutations in the 5' region of the myotubularin-related protein 2 (MTMR2) gene in autosomal recessive hereditary neuropathy with focally folded myelin. Brain 124:907-915
185. Kokame K, Kato H, Miyata T (1996) Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. GRP78/BiP and novel genes. J Biol Chem 271:29659-29665
186. Belzen N van, Dinjens WN, Diesveld MP, Groen NA, Made AC van der, Nozawa Y, Vlietstra R, Trapman J, Bosman FT (1997) A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. Lab Invest 77:85-92
187. Kurdistani SK, Arizti P, Reimer CL, Sugrue MM, Aaronson SA, Lee SW (1998) Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. Cancer Res 58:4439-4444
188. Zhou D, Salnikow K, Costa M (1998) Cap43, a novel gene specifically induced by Ni2+ compounds. Cancer Res 58:2182-2189
189. Agarwala KL, Kokame K, Kato H, Miyata T (2000) Phosphorylation of RTP, an ER stress-responsive cytoplasmic protein. Biochem Biophys Res Commun 272:641-647
190. Julien JP (1999) Neurofilament functions in health and disease. Curr Opin Neurobiol 9:554-560
191. De Jonghe P, Mersivanova I, Nelis E, Del Favero J, Martin JJ, Van Broeckhoven C, Evgrafov O, Timmerman V (2001) Further evidence that neurofilament light chain gene mutations can cause Charcot-Marie-Tooth disease type 2E. Ann Neurol 49:245-249
192. Zhu Q, Couillard-Despres S, Julien JP (1997) Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments. Exp Neurol 148:299-316
193. Lee MK, Marszalek JR, Cleveland DW (1994) A mutant neurofilament subunit causes massive, selective motor neuron death: implications for the pathogenesis of human motor neuron disease. Neuron 13:975-988
194. Soltysik-Espanola M, Rogers RA, Jiang S, Kim TA, Gaedigk R, White RA, Avraham H, Avraham S (1999) Characterization of Mayven, a novel actin-binding protein predominantly expressed in brain. Mol Biol Cell 10:2361-2375
195. Robinson DN, Cooley L (1997) Drosophila kelch is an oligomeric ring canal actin organizer. J Cell Biol 138:799-810
196. Koch T, Schultz P, Williams R, Lampert P (1977) Giant axonal neuropathy: a childhood disorder of microfilaments. Ann Neurol 1:438-451
197. Treiber-Held S, Budjarjo-Welim H, Reimann D, Richter J, Kretzschmar HA, Hanefeld F (1994) Giant axonal neuropathy: a generalized disorder of intermediate filaments with longitudinal grooves in the hair. Neuropediatrics 25:89-93
198. Ouvrier RA (1989) Giant axonal neuropathy. A review. Brain Dev 11:207-214
199. Waegh SM de, Lee VM, Brady ST (1992) Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 68:451-463
200. Sahenk Z, Chen L, Mendell JR (1999) Effects of PMP22 duplication and deletions on the axonal cytoskeleton. Ann Neurol 45:16-24
201. Parkinson NJ, Olsson CL, Hallows JL, McKee-Johnson J, Keogh BP, Noben-Trauth K, Kujawa SG, Tempel BL (2001) Mutant beta-spectrin 4 causes auditory and motor neuropathies in quivering mice. Nat Genet 20:20